Vivici, a pioneering collaboration between DSM and Fonterra, has successfully concluded its seed funding round, marking a significant milestone in its journey. This innovative venture harnesses the power of precision fermentation to craft dairy protein ingredients devoid of animal sources. Notably, both DSM-Firmenich Venturing and Fonterra serve as the founding investors in Vivici, underlining their commitment to driving progress in dairy innovation.
At its core, Vivici draws upon the rich reservoirs of knowledge and experience held by DSM and Fonterra in the domains of bioprocess development and dairy protein isolation. This strategic synergy positions Vivici to spearhead advancements in dairy science and technology, as it seeks to combine DSM-Firmenich’s precision fermentation prowess with Fonterra’s deep-rooted dairy expertise. The amalgamation of these industry leaders’ strengths is poised to propel Vivici to the forefront of dairy innovation.
Pieter Wolters, the managing director of DSM-Firmenich Venturing, has lauded Vivici’s robust foundation, affirming its newfound status as an agile startup. With this successful seed funding round under its belt, Vivici is primed to embark on a transformative journey, charting the course toward a future where animal-free dairy protein ingredients revolutionize the food industry.
